Crizotinib in ALK Rearranged Non-small-cell Lung Cancer
Clinical trial NCT04317651 · UNKNOWN
Trial details
- NCT number
- NCT04317651
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-16
- Primary completion
- 2021-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.